Lipid metabolism has emerged as a central player in the progression and therapy resistance of breast cancer, particularly the aggressive subtype known as triple-negative breast cancer (TNBC).

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck ...

Pilatus Biosciences, pioneering biologics targeting metabolic checkpoints, will present new research on its lead candidate, PLT012, at the American Association for Cancer Research (AACR) 2025 Annual ...

Cardiac sarcoidosis (CS) was a complication in about 10% of pulmonary sarcoidosis (PS) cases, investigators reported in Respiratory Medicine. The retrospective study assessed the prevalence, incidence ...

When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...

Researchers have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive ...

Chinese scientists have revealed a hidden metabolic partnership between breast cancer cells and immune cells that drives aggressive tumor behavior and resistance to immunotherapies. The study sheds ...